Navigation Links
Spice Girl Geri Halliwell Annoyed by the no Baby Contract

Spice girl Geri Halliwell is reportedly annoyed, for her upcoming tour bosses have asked her to sign a contract banning her from having kids till the gig is over .

According to a source, although the pop singer was not planning to have another baby soon, she was bugged by the contract as no other band member was asked to sign such contract.

Its just a practical requirement really, Geri isnt planning to get pregnant but she was narked that she was the only one approached about it, the Daily Star quoted the source, as saying.

Meanwhile if there was anything to go by rumours, Halliwell, who is currently dating 26-year-old Evgeny Lebedev, was looking forward to having a sibling for her 14-month-old daughter Bluebell, and did not want a long gap between her two kids.

While the 34-year-old singer is annoyed by the contract, her bandmates feel that the offer was flattering, for it shows that Halliwell was one of the powerhouses of the group.

Geri is one of the powerhouses of the group, so its flattering really, the source said.

The source however insisted that the singer was ready to sign up the contract because although she wanted another baby, he bands reunion was her priority.

Geri is happy to sign anything that backs up her commitment as, even though she wants a baby, this reunion comes first, the source said.


'"/>




Page: 1

Related medicine news :

1. Spices Could Be Employed To Treat Certain Cancers
2. Drawing from Myth to Become Mistress of Spices
3. Spices and Herbal Tea Help in Losing Weight
4. Spices in curries spruce up aging minds
5. Posh Puts the Spice Girls on a Diet
6. Computer Power to Give Spice Girls Weak Voices a Boost!
7. Scary Spice Shedding Weight for Reunion Tour
8. Ginger Spice Determined to Win Bulimia Battle
9. Sporty Spice Fears That She Might Never Get Pregnant
10. Rural Doctors In UP Annoyed Over Attendance Issue
11. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
Post Your Comments:
(Date:5/16/2008)...eclaring that Primary care medicine is in a precip...of the American College of Physicians (ACP), today... and consumers to issue a call for comprehensive r...rnists and other primary care physicians. , Dur...e medicine in the U.S., Dr. Dale and other panelis...
(Date:5/16/2008)...la., May 16 /PRNewswire-USNewswire/- "Huh, what di...mericans, particularly our,children. More than 30 ...e,significant hearing loss and the numbers are gro... school age children have some form of hearing,los...l and economic problem,is what led Kathlyn Maguire...
(Date:5/16/2008)...ndraiser Seeks to Raise $38 Million for Life-threa...-USNewswire/ -- Walkers in nearly,every state will...ay 17 and,18 -- by participating in GREAT STRIDES,...ibrosis Foundation announced today., May is Natio...is is a,life-threatening genetic disease that caus...
(Date:5/16/2008)...Urban Health Institute with 10,000 Sensual O Condo...Playboy Mansion Fundraiser, LOS ANGELES, May 16 /...,and R & B artist J Kwon known best for his hit so...presenting the Urban Health Institute (UHI) with,1...$50,000. The donation is,being made to promote the...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Everybody in the Club Scream O! 2
...elivered a male child on Wednesday at Holtz Childr... heart disorder called Ectopia// cordis. Seven or ... defect. The baby named Naseem, was born with his...one or sternum and the protective cover for the he...
...verweight children may have sleep problems that re... study which was published in the November issue o... 25 out of 100 overweight, inactive children teste...ng, including telltale snoring. After about three...
...y will be able to answer this question within the ...nternational study called TRIGR// (Trial to Reduce...by University of Helsinki, Finland, will research ...cation may prevent type 1 diabetes later in childh...
...o strengthen fragile, aging bones may also be prot...ed by Johns Hopkins// rheumatologist Clifton Bingh...te might be used to treat osteoarthritis after not...nds in the same class of drugs, not only slowed jo...
Other Medicine News:Health News:Naseem’s Heart Put In Its Plac 2Health News:Overweight Children Tested Positive For Sleep Disorders 2Health News:Overweight Children Tested Positive For Sleep Disorders 3Health News:Can Early Nutritional Modification Prevent Type 1 Diabetes? 2Health News:Millions with Arthritis May Benefit from Bone Loss Drug 2
(Date:5/16/2008)...-- Results demonstrating that TYKERB and trastuzum...tension of progression-free survival (PFS), -- Co...inside and,outside of the HER2 receptor may create...ting activity of TYKERB alone despite patients,pr...b and chemotherapy, LONDON and PHILADELPHIA, May ...
(Date:5/16/2008)...l Biomarkers -- for Lung Cancer Diagnosis and, Ide...r of Unknown Primary ...Types With High Sensitivity and, Specificity and...ncer Results of microRNA Signature to Identify Ti...ding 90% and Specificity of 99%, REHOVOT, Israel ...
(Date:5/16/2008)...al Mechanism May Offer Novel Approach to Blood ...LEANS, May 16 /- Pharmacope...nd development of novel small,molecule therapeutic...ss,Dual Acting Receptor Antagonist (DARA), showed ...s in a Phase 2a study in patients with mild to,mod...
(Date:5/15/2008)...fficacy for Population Most Affected by Disease -,...wswire-FirstCall/ --,Bayer HealthCare Pharmaceutic... ONXX ) today announced that Nexavar(R) (sorafenib...by 47.3 percent (HR=0.68;,p-value=0.014) in patien...cellular carcinoma (HCC), or primary liver cancer ...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 1A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 2Virus Shows Some Cancer Killing Abilities 5014 1Virus Shows Some Cancer Killing Abilities 5014 2Virus Shows Some Cancer Killing Abilities 5014 3Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 1Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 2Vitamin D Wont Help Prevent Most Cancers 5012 1Vitamin D Wont Help Prevent Most Cancers 5012 2Vitamin D Wont Help Prevent Most Cancers 5012 3
...aracterization and Broad,Neuroprotective Propertie...imental Therapeutics , Neurodegenerative Disease S...te for ALS That Targets Mitochondrial Proteins , M...aceutical,company specializing in the discovery an... announced today that a publication entitled,"Iden...
... AMADEO, one of the,first studies to compare the ...lockers in hypertensive patients with,diabetic ne...of Hypertension, Milan. The results from this stud...significantly greater extent,than losartan.(1) ...ess, Foothills Hospital,in Calgary, Canada said "...
Other Medicine Technology:Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: